Tech Center 3700 • Art Units: 3792 3796
This examiner grants 34% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17299869 | METHOD OF CONTROLLING CABLE DRIVEN END EFFECTORS | Final Rejection | Covidien LP |
| 18620008 | BIOLOGICAL INFORMATION MEASUREMENT APPARATUS AND BIOLOGICAL INFORMATION MEASUREMENT SET | Non-Final OA | SEIKO EPSON CORPORATION |
| 18753787 | Bolus Stimulation in a Neurostimulation Device Particularly Useful in Providing Sub-Perception Stimulation | Final Rejection | Boston Scientific Neuromodulation Corporation |
| 18497665 | Spinal Cord Stimulation Occurring Using Monophasic Pulses of Alternating Polarities and Passive Charge Recovery | Final Rejection | Boston Scientific Neuromodulation Corporation |
| 16354420 | DUAL MODE CONTROLS FOR ROBOTIC SURGERY | Final Rejection | Cilag GmbH International |
| 17159764 | SURGICAL SYSTEM INSTRUMENT MANIPULATOR | Final Rejection | INTUITIVE SURGICAL OPERATIONS, INC. |
| 17673369 | APPARATUS FOR MOVING A MEDICAL OBJECT AND METHOD FOR PROVIDING A CONTROL INSTRUCTION | Final Rejection | Siemens Healthcare GmbH |
| 18572014 | IMPEDANCE TOMOGRAPHY SYSTEM FOR ALIGNMENT FEEDBACK OF A CHARGING DEVICE FOR AN IMPLANTABLE MEDICAL DEVICE | Non-Final OA | BIOTRONIK SE & Co. KG |
| 18557123 | METHOD FOR ASSIGNING AN ITEM OF IDENTIFICATION INFORMATION TO A SIGNAL FROM A CARDIAC ELECTRODE | Final Rejection | BIOTRONIK SE & Co. KG |
| 18579222 | SYSTEMS AND METHODS FOR CONTROLLING A MEDICAL DEVICE USING BAYESIAN PREFERENCE MODEL BASED OPTIMIZATION AND VALIDATION | Non-Final OA | Regents of the University of Minnesota |
| 18472344 | INCONTINENCE THERAPY SCHEDULING | Final Rejection | Medtronic, Inc. |
| 17955607 | HEMATOCRIT SENSOR BASED ON IMPEDANCE MEASUREMENT IN CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICES | Final Rejection | Medtronic, Inc. |
| 17808424 | LEADLESS PACING DEVICE WITH CORONARY SINUS LEADLET | Final Rejection | Medtronic, Inc. |
| 17937025 | Artifact Removal from Electrodermal Activity Data | Final Rejection | THE GENERAL HOSPITAL CORPORATION |
| 19030761 | SYSTEMS AND METHODS FOR TREATING CARDIAC DYSFUNCTION THROUGH PERIPHERAL NERVE STIMULATION | Non-Final OA | Cala Health, Inc. |
| 17744557 | SYSTEMS AND METHODS FOR OPTIMIZING NERVE STIMULATION | Non-Final OA | ElectroCore, Inc. |
| 18098057 | SYSTEMS, METHODS, AND MEDIA FOR PREDICTING A CONVERSION TIME OF MILD COGNITIVE IMPAIRMENT TO ALZHEIMER'S DISEASE IN PATIENTS | Final Rejection | UNIVERSITY OF SOUTH FLORIDA |
| 18583032 | SYSTEMS AND METHODS FOR EXTENDED EGM COLLECTION AND UTILIZATION BY AN IMPLANTABLE MEDICAL DEVICE | Final Rejection | Pacesetter, Inc. |
| 19075143 | NEURAL INTERFACE TECHNOLOGY FOR COMMUNICATING WITH CLINICALLY UNRESPONSIVE PATIENTS | Final Rejection | PRECISION NEUROSCIENCE CORPORATION |
| 19058751 | SENSING SYSTEM WITH FEATURES FOR DETERMINING AND ENHANCING COGNITIVE RESERVE OF A SUBJECT | Non-Final OA | NeuroGeneces Inc. |
| 18652959 | VENTRICULAR ASSIST DEVICE WITH OPTICAL FIBER | Final Rejection | Magenta Medical Ltd |
| 17870353 | ELECTRODE LOCATING SYSTEMS AND METHODS FOR USE DURING A COCHLEAR IMPLANT LEAD INSERTION PROCEDURE | Final Rejection | Advanced Bionics AG |
| 18713859 | SWEAT SENSING DEVICE AND METHOD FOR FORMING THE SAME | Non-Final OA | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH |
| 17991810 | THERAPEUTIC MODULATION TO TREAT BLOOD GLUCOSE ABNORMALITIES, INCLUDING TYPE 2 DIABETES, AND/OR REDUCE HBA1C LEVELS, AND ASSOCIATED SYSTEMS AND METHODS | Final Rejection | Nevro Corp. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy